ConductScience.org, home

Gene · 6548

NIH grants1,862

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleSLC9A1 papersNewest fiscal year
F30CA284809Molecular MR-PET to characterize malignant transformation and identify therapeutic vulnerabilities in human IDH-mutant gliomas12025
F31HL170503The Role of Mitochondrial Acid-Sensing Ion Channel 1 in Pulmonary Hypertension12025
I01BX001245Luminal Factors Affecting Duodenal Protection and Chemosensing12025
I01BX001991Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis12025
I01BX002891SPAK inhibitor ZT-1a for ischemic stroke therapy12025
I01BX004024Transport and metabolism in the kidney12025
I01BX005952Multi-scale MRI Assessment of Bone Quality and Function in a Chronic Rat Spinal Cord Injury Model12025
IK2BX005376A Role of Isolevuglandins in Essential Hypertension and Systemic Lupus Erythematosus12025
K08AG070053The Role of the Tau in Homeostatic Scaling and Mechanisms of Alzheimer's Disease12025
K08HL161445The Role of SECTM1 in Monocyte Biology and Atherosclerosis12025
K12HD000850Pediatric Scientist Development Program12025
K23MH127303Organellar Na+/H+ Exchangers and Intracellular pH Regulation in Schizophrenia Brain12025
P01AI125181Pathogenesis of E. coli and Shigella infections in human enteroid models12025
P01AI131251SHIV Env-antibody coevolution as a molecular guide to HIV-1 V3 glycan targeted vaccine design12025
P01HL116263HDL Function in Human Disease12025
P01HL141084Multiscale Systems to Elucidate Susceptibility and Cardioprotective Mechanisms in Cardio-oncology12025
P20GM103418Kansas IDeA Network of Biomedical Research Excellence 512025
P20GM103449Vermont Biomedical Research Network-Vermont INBRE12025
P20GM113132The Institute for Biomolecular Targeting12025
P20GM113226Hepatobiology and Toxicology COBRE12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/6548/grants?page=4